Effect of dietary supplement firms ART LIFE IVLAKSIN on the course of acute broncho-pulmonary and respiratory diseases.
LG Lenski, Regional Hospital, Tomsk
1. The purpose and objectives of the study
1.1. The purpose of the study - assessment of effectiveness and impact of biologically active additives (BAA) IVLAKSIN in patients with inflammatory diseases of upper respiratory tract.
1.2. Clinical evaluation of dietary supplements ART LIFE IVLAKSIN carried on the following indicators: assessment of the color of the skin, the functional state of the respiratory system, cardiovascular system, gastrointestinal tract, weight, laboratory data (complete blood count, general urinalysis, blood chemistry).
2. Materials and methods
2.1. In total, the dynamics were examined 10 people aged 23 to 50 years with acute respiratory disease (4 cases), pneumonia (3 cases), chronic tonsillitis (2 cases), influenza (3 cases). Associated pathology: asthenic syndrome - 2 cases, asthmatic bronchitis - 2 cases.
3. Results of the study
3.1. The analysis showed that in 10 observations of negative reactions to taking dietary supplements are not found in any case.
3.2. In patients with acute respiratory infections and flu for 1-2 days reduces swelling of nasal mucosa without local treatment, quickly passed the mucous laryngeal edema, hyperemia. Quickly recovered his voice. By the end of the second day of runny nose disappeared. Intoxication symptoms disappeared by the end of first - early second day. Blood tests returned to normal quickly.
3.3. In patients with pneumonia was a combined treatment. Decreased temperatures during the first and second days, symptoms of intoxication had disappeared by the end of the second or third day. Cough disappeared by 4-5 days. Phlegm off easily, odorless and tasteless. ESR returned to normal significantly faster: for 8-10 day. Leukocytosis, respectively, to 6.7 day.
3.4. In two cases of patients suffering from bronchitis at the age of 28 and 37 years, noted the absence of the usual acute respiratory exacerbation in asthmatic bronchitis.
3.5. Changes in the overall analysis of urine were noted.
3.6. Biochemical blood tests showed: total protein was normal except in two cases with a slight decrease, which recovered by the end of treatment. Sugar content, AST, ALT, and bilirubin were within normal limits.
3.7. Indicators of general blood analysis:
• White blood cells are up to 10x 109 / L - 6 people, more than 10x 109 / L - 4 people.
• ESR greater than 15 mm / h - 6 people, more than 30 mm / hour - 2 people.
3.8. Side effects when using supplements ART LIFE IVLAKSIN were noted.
3.9. Organoleptic properties were evaluated as satisfactory. Taste and smell pleasant. Unpleasant taste of a stranger is not mentioned.
Conclusion
During the application of BAA ART LIFE IVLAKSIN noted its good tolerability. Side effects were observed. This drug should be recommended as a restorative, preventive and supportive treatment for the following states:
• The flu epidemic;
• ARI;
• Pneumonia;
• Sinusitis;
• Rhinitis;
• Asthmatic bronchitis.
